子宫内膜异位症中的癌症相关突变:揭示发病机制与病理生理学
本文综述了子宫内膜异位症中癌症相关突变(CAMs)的研究,检索PubMed至2019年9月的文献,纳入7篇测序研究。不同测序方法检出率差异大,显微切割和更精确测序方法检出更多CAMs。CAMs可能源于复制性衰老和氧化应激,与纤维化相关,并可能增加癌变风险和治疗抵抗。
要点
- 显微切割和精确测序方法可检出更多CAMs,健康组织也存在复制性衰老相关的CAMs。
- 异位子宫内膜上皮细胞因周期性出血更新快,突变频率高于间质细胞。
- 携带CAMs的病灶可能因高纤维化、低血管化和低细胞性而对药物治疗更抵抗。
核心结论
- 子宫内膜异位症病灶普遍存在体细胞突变和癌症相关突变(CAMs),可能源于复制性衰老和氧化应激。
- CAMs可能参与病灶纤维化,并与雌激素过多和氧化应激共同驱动发病。
- 携带CAMs的病灶可能对药物治疗更抵抗,但CAMs与癌变风险的关联尚不明确。
研究设计与样本
- 综述,检索PubMed数据库至2019年9月,纳入7篇使用不同测序方法检测子宫内膜异位症CAMs的英文文献。
主要发现
- 不同测序方法报道的突变频率差异较大,显微切割和更精确测序方法检出更多CAMs。
- 异位子宫内膜上皮细胞突变频率高于间质细胞,可能与上皮细胞更新更快有关。
- 健康组织也可检测到CAMs,作为复制性衰老的一部分。
- CAMs相关基因可能参与病灶纤维化,高雌激素和氧化应激可能是CAMs和纤维化的驱动因素。
临床怎么用
- 对子宫内膜异位症病灶进行突变分析可能有助于识别治疗抵抗风险较高的患者。
- 未来需对不同年龄和生育史女性的正常子宫内膜进行突变谱分析,以深入理解发病机制。
- 表观遗传学在异位、在位和正常子宫内膜中的作用值得进一步研究。
局限性
- 已发表数据仍无法清晰描绘子宫内膜异位症的发病机制。
- CAMs与癌症风险的关系尚不明确,需进一步研究。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Endometriosis is a benign gynaecological disease. Thus, it came as a complete surprise when it was reported recently that the majority of deep endometriosis lesions harbour somatic mutations and a sizeable portion of them contain known cancer-associated mutations (CAMs). Four more studies have since been published, all demonstrating the existence of CAMs in different subtypes of endometriosis. While the field is still evolving, the confirmation of CAMs has raised many questions that were previously overlooked. OBJECTIVE AND RATIONALE: A comprehensive overview of CAMs in endometriosis has been produced. In addition, with the recently emerged understanding of the natural history of endometriotic lesions as well as CAMs in normal and apparently healthy tissues, this review attempts to address the following questions: Why has there been such a wild discrepancy in reported mutation frequencies? Why does ectopic endometrium have a higher mutation rate than that of eutopic endometrium? Would the presence of CAMs in endometriotic lesions increase the risk of cancer to the bearers? Why do endometriotic epithelial cells have much higher mutation frequencies than their stromal counterpart? What clinical implications, if any, do the CAMs have for the bearers? Do these CAMs tell us anything about the pathogenesis and/or pathophysiology of endometriosis? SEARCH METHODS: The PubMed database was searched, from its inception to September 2019, for all papers in English using the term 'endometriosis and CAM', 'endometriosis and cancer-driver mutation', 'somatic mutations', 'fibrosis', 'fibrosis and epigenetic', 'CAMs and tumorigenesis', 'somatic mutation and normal tissues', 'oestrogen receptor and fibrosis', 'oxidative stress and fibrosis', 'ARID1A mutation', and 'Kirsten rat sarcoma mutation and therapeutics'. All retrieved papers were read and, when relevant, incorporated into the review results. OUTCOMES: Seven papers that identified CAMs in endometriosis using various sequencing methods were retrieved, and their results were somewhat different. Yet, it is apparent that those using microdissection techniques and more accurate sequencing methods found more CAMs, echoing recent discoveries that apparently healthy tissues also harbour CAMs as a result of the replicative aging process. Hence endometriotic lesions, irrespective of subtype, if left intact, would generate CAMs as part of replicative aging, oxidative stress and perhaps other factors yet to be identified and, in some rare cases, develop cancer. The published data still are unable to paint a clear picture on pathogenesis of endometriosis. However, since endometriotic epithelial cells have a higher turnover than their stromal counterpart due to cyclic bleeding, and since the endometriotic stromal component can be formed by refresh influx of mesenchymal cells through epithelial-mesenchymal transition, endothelial-mesenchymal transition, mesothelial-mesenchymal transition and other processes as well as recruitment of bone-marrow-derived stem cells and outflow due to smooth muscle metaplasia, endometriotic epithelial cells have much higher mutation frequencies than their stromal counterpart. The epithelial and stromal cellular components develop in a dependent and co-evolving manner. Genes involved in CAMs are likely to be active players in lesional fibrogenesis, and hyperestrogenism and oxidative stress are likely drivers of both CAMs and fibrogenesis. Finally, endometriotic lesions harbouring CAMs would conceivably be more refractory to medical treatment, due, in no small part, to their high fibrotic content and reduced vascularity and cellularity. WIDER IMPLICATIONS: The accumulating data on CAMs in endometriosis have shed new light on the pathogenesis and pathophysiology of endometriosis. They also suggest new challenges in management. The distinct yet co-evolving developmental trajectories of endometriotic stroma and epithelium underscore the importance of the lesional microenvironment and ever-changing cellular identity. Mutational profiling of normal endometrium from women of different ages and reproductive history is needed in order to gain a deeper understanding of the pathogenesis. Moreover, one area that has conspicuously received scant attention is the epigenetic landscape of ectopic, eutopic and normal endometrium.
引用
- Guo SW. Cancer-associated mutations in endometriosis: shedding light on the pathogenesis and pathophysiology. Hum Reprod Update. 2020. PMID: 32154564. doi:10.1093/humupd/dmz047
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。